{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:57:41Z","timestamp":1790611061189,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.anpede.2026.504315","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:59:37Z","timestamp":1788983977000},"page":"504315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulation and analysis of the access to orphan drugs in the pediatric population in Spain"],"prefix":"10.1016","volume":"105","author":[{"given":"Paula del","family":"R\u00edo G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ca\u00ed\u00f1a L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"D\u00e1vila Pousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2026.504315_bib0005","unstructured":"M.D. Edo Solsona, M.J. Company Albir and J.L. Poveda Andr\u00e9s, Farmacia Hospitalaria para pacientes con Enfermedades Raras [Internet] 2021 [access el 24 de enero de 2025]. Available from: https:\/\/gruposdetrabajo.sefh.es\/orpharsefh\/images\/stories\/documentos\/farmacia-hospitalaria-pacientes-enfermedades-raras.pdf."},{"key":"10.1016\/j.anpede.2026.504315_bib0010","unstructured":"Punto Farmacol\u00f3gico. Enfermedades raras y medicamentos hu\u00e9rfanos [Internet]. Farmaceuticos.com. [access el 24 de enero de 2025]. Available from: https:\/\/www.farmaceuticos.com\/wp-content\/uploads\/2023\/02\/Punto-Farmacologico-167-EERR-y-MMHH.pdf."},{"key":"10.1016\/j.anpede.2026.504315_bib0015","unstructured":"Enfermedades Raras [Internet]. CIBERER.es [access el 19 de febrero de 2026]. Available from: https:\/\/www.ciberer.es\/quienes-somos\/enfermedades-raras."},{"key":"10.1016\/j.anpede.2026.504315_bib0020","unstructured":"Las enfermedades raras en los ni\u00f1os. [Internet]. Odontologiapediatrica.com. [access el 24 enero de 2025]. Available from: https:\/\/www.odontologiapediatrica.com\/wp-content\/uploads\/2018\/06\/Las_enfermedades_raras_en_los_ni%C3%B1os.pdf."},{"issue":"Suppl 2","key":"10.1016\/j.anpede.2026.504315_bib0025","first-page":"9","article-title":"Enfermedades raras. Concepto, epidemiolog\u00eda y situaci\u00f3n actual en Espa\u00f1a [Rare diseases. Concept, epidemiology and state of the question in Spain]","volume":"31","author":"Posada De la Paz","year":"2008","journal-title":"An Sist Sanit Navar."},{"key":"10.1016\/j.anpede.2026.504315_bib0030","unstructured":"Enfermedades raras en cifras. Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras (FEDER) [Internet]. Enfermedades-raras.org. [access el 24 de enero de 2025]. Available from: https:\/\/www.enfermedades-raras.org\/enfermedades-raras\/conoce-mas-sobre-er\/enfermedades-raras-en-cifras."},{"key":"10.1016\/j.anpede.2026.504315_bib0035","unstructured":"Estrategia en Enfermedades Raras del Sistema Nacional de Salud [Internet]. Gob.es. [access el 30 de enero de 2025]. Available from: https:\/\/www.sanidad.gob.es\/areas\/calidadAsistencial\/estrategias\/enfermedadesRaras\/docs\/Estrategia_Enfermedades_Raras_SNS_2014.pdf."},{"issue":"1","key":"10.1016\/j.anpede.2026.504315_bib0040","article-title":"Farmacotecnia en Enfermedades Raras","volume":"11","author":"Feal Cortizas","year":"2023","journal-title":"Bolet\u00edn Farmacotecnia."},{"key":"10.1016\/j.anpede.2026.504315_bib0045","unstructured":"E. Bermejo-S\u00e1nchez, J. Carri\u00f3n Tudela, V. Alonso Ferreira, M. Posada de la Paz, C. Hern\u00e1ndez Garc\u00eda, J.M. Fontanet Sacrist\u00e1n, et al., Libro Blanco de las Enfermedades Raras en Espa\u00f1a, 2018 [access el 30 de enero de 2025]. Available from: https:\/\/www.enfermedades-raras.org\/sites\/default\/files\/documentos\/el-libro-blanco-de-las-enfermedades-raras-en-espana.pdf."},{"issue":"1","key":"10.1016\/j.anpede.2026.504315_bib0050","article-title":"Medicamentos hu\u00e9rfanos: regulaci\u00f3n y controversias","volume":"23","author":"Garj\u00f3n Parra","year":"2015","journal-title":"Bolet\u00edn de informaci\u00f3n farmacoterap\u00e9utica de Navarra [Internet]"},{"key":"10.1016\/j.anpede.2026.504315_bib0055","unstructured":"Orphanet: Sobre los medicamentos hu\u00e9rfanos [Internet]. Orpha.net. [access el 30 de enero de 2026]. Available from: https:\/\/www.orpha.net\/es\/other-information\/about-orphan-drugs."},{"key":"10.1016\/j.anpede.2026.504315_bib0060","series-title":"Desarrollo de Medicamentos Hu\u00e9rfanos para Enfermedades Raras","article-title":"Gu\u00eda r\u00e1pida para investigadores","author":"Bl\u00e1zquez P\u00e9rez","year":"2016"},{"key":"10.1016\/j.anpede.2026.504315_bib0065","unstructured":"Exclusividad en el mercado [Internet]. Eupati.eu. [access el 30 de mayo de 2025]. Available from: https:\/\/toolbox.eupati.eu\/glossary\/exclusividad-en-el-mercado\/?lang=es&print=pdf."},{"key":"10.1016\/j.anpede.2026.504315_bib0070","unstructured":"Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Document 32000R0141 [Internet] 26 de julio de 2019 [access el 30 de mayo de 2023]. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32000R0141."},{"key":"10.1016\/j.anpede.2026.504315_bib0075","unstructured":"Reglamento (CE) n\u00ba 1901\/2006 del Parlamento Europeo y del Consejo de 12 de diciembre de 2006 sobre medicamentos para uso pedi\u00e1trico y por el que se modifican el Reglamento (CEE) N\u00ba 1768\/92, la Directiva 2001\/20\/CE, la Directiva 2001\/83\/CE y el Reglamento (CE) n\u00ba 726\/2004. Diario Oficial de la Uni\u00f3n Europea [Internet] 27 de diciembre de 2006 [access el 30 de mayo de 2025]. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/ES\/TXT\/PDF\/?uri=CELEX:32006R1901&from=EN."},{"key":"10.1016\/j.anpede.2026.504315_bib0080","unstructured":"Informe de evaluaci\u00f3n de la financiaci\u00f3n y fijaci\u00f3n del precio de los Medicamentos Hu\u00e9rfanos en el SNS (2016-2021) [Internet] 2022 [access el 30 de mayo de 2025]. Available from: https:\/\/www.sanidad.gob.es\/areas\/farmacia\/publicaciones\/informes\/docs\/202202222_Infor_Evol_Mtos_Huerfanos_SNS_2016_2021.pdf."},{"key":"10.1016\/j.anpede.2026.504315_bib0085","unstructured":"Reglamento (CE) no 726\/2004 del Parlamento Europeo y del Consejo de 31 de marzo de 2004. Bolet\u00edn Oficial del Estado [Internet] 30 de abril de 2004 [access el 30 de mayo de 2025]. Available from: https:\/\/www.boe.es\/buscar\/doc.php?id=DOUE-L-2004-80948."},{"key":"10.1016\/j.anpede.2026.504315_bib0090","unstructured":"N. Zozaya, R. Villoro, A. Hidalgo and A. Sarria, Criterios de financiaci\u00f3n y reembolso de los medicamentos hu\u00e9rfanos [Internet] 2016 [access el 30 de mayo de 2025]. Available from: https:\/\/repisalud.isciii.es\/rest\/api\/core\/bitstreams\/a1c8355d-0a98-4a44-a34a-6cf58d00265c\/content."},{"key":"10.1016\/j.anpede.2026.504315_bib0095","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. CIMA: Resultados de la b\u00fasqueda de medicamentos [Internet]. Aemps.es. [access el 30 de enero de 2026]. Available from: https:\/\/cima.aemps.es\/cima\/publico\/lista.html."},{"key":"10.1016\/j.anpede.2026.504315_bib0100","unstructured":"EMA. Download medicine data. European Medicines Agency. [Internet] 2018 [access el 30 de enero de 2026]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/download-medicine-data."},{"key":"10.1016\/j.anpede.2026.504315_bib0105","unstructured":"Pediam\u00e9cum [Internet]. Aeped.es. [access el 30 de enero de 2026]. Disponible en: https:\/\/www.aeped.es\/comite-medicamentos\/pediamecum."},{"key":"10.1016\/j.anpede.2026.504315_bib0110","unstructured":"Community Register of orphan medicinal products [Internet]. European Commission [access el 30 de enero de 2026]. Available from: https:\/\/ec.europa.eu\/health\/documents\/community-register\/html\/reg_od_act.htm?sort=a."},{"key":"10.1016\/j.anpede.2026.504315_bib0115","unstructured":"AELMHU. Informe Anual de Acceso 2025 de los Medicamentos hu\u00e9rfanos en Espa\u00f1a [Internet] 2025 [access el 30 de enero de 2026]. Available from: https:\/\/aelmhu.es\/wp-content\/uploads\/2026\/01\/RESUMEN-EJECUTIVO-INFORME-DE-ACCESO-2025_AELMHU_DEF.pdf."},{"key":"10.1016\/j.anpede.2026.504315_bib0120","unstructured":"Medicines output orphan designations [Internet]. EMA. europa.eu [access el 8 de enero de 2026]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/download-medicine-data#orphan-designations-69050."},{"key":"10.1016\/j.anpede.2026.504315_bib0125","unstructured":"Ministerio de Sanidad - Profesionales de la Salud - BIFIMED: Buscador de la Informaci\u00f3n sobre la situaci\u00f3n de financiaci\u00f3n de los medicamentos - Nomencl\u00e1tor [Internet] Gob.es [access el 30 de enero de 2026]. Available from: https:\/\/www.sanidad.gob.es\/profesionales\/medicamentos.do."},{"issue":"4","key":"10.1016\/j.anpede.2026.504315_bib0130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40272-021-00455-1","article-title":"Navigating the regulatory landscape to develop pediatric oncology drugs: expert opinion recommendations","volume":"23","author":"Barry","year":"2021","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.anpede.2026.504315_bib0135","unstructured":"T. De Jongh, J. van Belle, A. de Ruiter, T. Guznajeva, V. Bastiiaanseen, E. Pottinger, et al., Study to support the evaluation of the EU Orphan Regulation [Internet] 2019 [access el 30 de mayo de 2026]. Available from: https:\/\/health.ec.europa.eu\/system\/files\/2020-08\/orphan-regulation_study_final-report_en_0.pdf."},{"key":"10.1016\/j.anpede.2026.504315_bib0140","unstructured":"Real Decreto 1015\/2009, de 19 de junio, por el que se regula la disponibilidad de medicamentos en situaciones especiales. Bolet\u00edn Oficial del Estado [Internet] 20 de julio de 2009 [access el 30 de mayo de 2025]. Available from: https:\/\/www.boe.es\/buscar\/doc.php?id=BOE-A-2009-12002."},{"issue":"6","key":"10.1016\/j.anpede.2026.504315_bib0145","first-page":"380","article-title":"Bases para el uso cl\u00ednico de f\u00e1rmacos para ni\u00f1os. Situaci\u00f3n actual de uso de f\u00e1rmacos pedi\u00e1tricos en Espa\u00f1a","volume":"6","author":"Medina-Claros","year":"2008","journal-title":"An Pediatr Contin."},{"key":"10.1016\/j.anpede.2026.504315_bib0150","unstructured":"Plataforma Online de F\u00f3rmulas Magistrales en Enfermedades Raras [Internet]. Sociedad Espa\u00f1ola de Farmacia Hospitalaria (SEFH) [access el 24 de enero de 2025]. Available from: https:\/\/www.sefh.es\/formulas-eerr\/."},{"key":"10.1016\/j.anpede.2026.504315_bib0155","unstructured":"Red \u00daNICAS [Internet]. Gob.es. [access el 19 de febrero de 2026]. Available from: https:\/\/unicas-fhir.sanidad.gob.es\/proyectoRedUNICAS.html."},{"key":"10.1016\/j.anpede.2026.504315_bib0160","unstructured":"Registro de Pacientes de Enfermedades Raras [Internet]. Instituto Salud Carlos III (isciii.es) [access el 19 de febrero de 2026]. Available from: https:\/\/registroraras.isciii.es\/Comun\/Inicio.aspx#secc-ProfesionalSalud."}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287926003200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287926003200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:26:39Z","timestamp":1790609199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287926003200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2341287926003200"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2026.504315","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation and analysis of the access to orphan drugs in the pediatric population in Spain","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2026.504315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2026.504315","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"504315"}}